from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3429/PPE59

LFCtreatmentdescriptionclass of inhibitor

1.076

Amikacinug/mL Amikacintranslation

0.603

Cap5-10ug/mL Capreomycintranslation

1.822

Rox10-50 ug/mL Roxithromycintranslation

0.753

SM2-5 ug/mL Streptomycintranslation

1.012

Tet5-10 ug/mL Tetracyclinetranslation

-0.749

Rif0.2-5ug/mL Rifampicintranscription

0.050

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.094

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.697

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.106

CPZ10-50 ug/mL Chlorpromazinerespiration

0.171

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.533

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.961

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.393

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.143

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.662

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.515

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.336

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.688

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.336

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.381

KCN5-20 ug/mL Potassium cyaniderespiration

0.124

NaN30.2-2 mM Sodium aziderespiration

-0.267

Nigericin50 uM Nigericinrespiration

-0.398

TRC10-150 ug/mL Triclosanrespiration

0.337

TRZ10-25 ug/mL Thioridazinerespiration

2.219

Valinomycin0.5-10 uM Valinomycinrespiration

-0.598

ZnSO42 mM ZnSO4respiration

-0.239

menadione6-10 ug/mL Menadionerespiration

-0.396

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.250

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.558

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.176

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.009

NRP_1Non-replicating persistence stage 1dosRassociated

-0.317

Amp0.2mg/mL AmpicillincellWall

-0.268

Cephalexin20-100 ug/mL CephalexincellWall

-0.164

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.685

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.207

EMB10-20 ug/mL EthambutolcellWall

0.002

Eta12-40 ug/mL EthionamidecellWall

0.533

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.164

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.607

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.296

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.240

BZA0.12 mg/mL BenzamidearomaticAmides

0.241

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.407

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.166

H2O24 mM hydrogen peroxideDNAdamaging

-0.970

Levo10 ug/mL LevofloxacinDNAdamaging

-0.561

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.072

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.217

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.556

UVUV-irradiationDNAdamaging

-1.216

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.867

Antimycin12.5-50 ug/mL Antimycin A?

-0.320

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.487

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.572

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.990

PA8240.2-2 ug/mL PA-824?

2.208

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.518

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.174

Verapamil50 uM Verapamil?

-0.273

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.629

methoxatin10-20 ug/mL Methoxatin?